Comparative molecular field analysis of in vitro growth inhibition of L1210 and HCT-8 cells by some pyrazoloacridines

In vitro screening of a number of 2-(aminoalkyl)-5-nitropyrazolo[3,4,5- kl]acridines has previously indicated (Sebolt, J.S.; et al. Cancer Res. 1987, 47, 4299-4304) that these compounds, in general, exhibit selective cytotoxicity against the human colon adenocarcinoma, HCT-8, cell line, relative to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 1993-11, Vol.36 (23), p.3511-3516
Hauptverfasser: Horwitz, Jerome P, Massova, Irina, Wiese, Thomas E, Wozniak, Antoinette J, Corbett, Thomas H, Sebolt-Leopold, Judith S, Capps, David B, Leopold, Wilbur R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3516
container_issue 23
container_start_page 3511
container_title Journal of medicinal chemistry
container_volume 36
creator Horwitz, Jerome P
Massova, Irina
Wiese, Thomas E
Wozniak, Antoinette J
Corbett, Thomas H
Sebolt-Leopold, Judith S
Capps, David B
Leopold, Wilbur R
description In vitro screening of a number of 2-(aminoalkyl)-5-nitropyrazolo[3,4,5- kl]acridines has previously indicated (Sebolt, J.S.; et al. Cancer Res. 1987, 47, 4299-4304) that these compounds, in general, exhibit selective cytotoxicity against the human colon adenocarcinoma, HCT-8, cell line, relative to mouse leukemia L1210 cells. Comparative molecular field analysis (CoMFA) was applied to HCT-8 and L1210 growth inhibition assays (IC50s) of a series (44) of the pyrazoloacridine derivatives with the objective of predicting improved solid tumor selectivity. In the absence of crystallographic data, the 9-methoxy derivative (15), which is currently in clinical study, was selected as the template molecular model. Two different structural alignments were tested: an alignment of structures based on root mean square (RMS)-fitting of each structure to 15 was compared with an alternative strategy, steric and electrostatic alignment (SEAL). Somewhat better predictive cross-validation correlations (r2) were obtained with models based on RMS vis-à-vis SEAL alignment for both sets of assays. A large change in lattice spacing, e.g., 2 to 1 A, causes significant variations in the CoMFA results. A shift in the lattice of half of its spacing had a much smaller effect on the CoMFA data for a lattice of 1 A than one of 2 A. The relative contribution of steric and electrostatic fields to both models were about equal, underscoring the importance of both terms. Neither calculated log P nor HOMO and/or LUMO energies contribute to the model. Steric and electrostatic fields of the pyrazoloacridines are the sole relevant descriptors to the structure-activity (cross-validated and conventional) correlations obtained with the cytotoxic data for both the L1210 and HCT-8 cell lines. The cross-validated r2, derived from partial least-squares calculations, indicated considerable predictive capacity for growth inhibition of both the leukemia and solid-tumor data. Evidence for the predictive performance of the CoMFA-derived models is provided in the form of plots of actual vs predicted growth inhibition of L1210 and HCT-8 cells, respectively, by the pyrazoloacridines. The steric and electrostatic features of the QSAR are presented in the form of standard deviation coefficient contour maps of steric and electrostatic fields. The maps indicate that increases or decreases in steric bulk that would enhance growth inhibition of HCT-8 cells would likewise promote growth inhibition of L1210 cells. Conto
doi_str_mv 10.1021/jm00075a004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76074495</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76074495</sourcerecordid><originalsourceid>FETCH-LOGICAL-a383t-6ade218e7b69b314febc06db5d4897fb1a4ea8d5878252decc8da0e2283a5afd3</originalsourceid><addsrcrecordid>eNpt0cGLEzEUBvAgytpdPXkWchD3IKMvycwkPUrVXbFgwQq9hTdJxk2dmXSTmdX615vSUjx4CuH78Xj5QsgLBm8ZcPZu2wOArBCgfERmrOJQlArKx2QGwHnBay6eksuUtpkJxsUFuVBcAVfzGZkWod9hxNE_ONqHzpmpw0hb7zpLccBun3yioaV-oA9-jIH-iOHXeJfvd77xow_DIV0yziB7S28X60JR47ou0WZPU-gd3e0j_gldQBO99YNLz8iTFrvknp_OK_L908f14rZYfr35vHi_LFAoMRY1WseZcrKp541gZesaA7VtKluquWwbhqVDZSslFa-4dcYoi-A4VwIrbK24Iq-Pc3cx3E8ujbr36bAbDi5MScsaZFnOqwzfHKGJIaXoWr2Lvse41wz0oWT9T8lZvzyNnZre2bM9tZrzV6cck8GujTgYn84svw0kHFhxZD6N7vc5xvhT11LISq9X3_SXzYfN6mYl9Sb766NHk_Q2TDF_T_rvgn8BzGKgzA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76074495</pqid></control><display><type>article</type><title>Comparative molecular field analysis of in vitro growth inhibition of L1210 and HCT-8 cells by some pyrazoloacridines</title><source>MEDLINE</source><source>American Chemical Society (ACS) Journals</source><creator>Horwitz, Jerome P ; Massova, Irina ; Wiese, Thomas E ; Wozniak, Antoinette J ; Corbett, Thomas H ; Sebolt-Leopold, Judith S ; Capps, David B ; Leopold, Wilbur R</creator><creatorcontrib>Horwitz, Jerome P ; Massova, Irina ; Wiese, Thomas E ; Wozniak, Antoinette J ; Corbett, Thomas H ; Sebolt-Leopold, Judith S ; Capps, David B ; Leopold, Wilbur R</creatorcontrib><description>In vitro screening of a number of 2-(aminoalkyl)-5-nitropyrazolo[3,4,5- kl]acridines has previously indicated (Sebolt, J.S.; et al. Cancer Res. 1987, 47, 4299-4304) that these compounds, in general, exhibit selective cytotoxicity against the human colon adenocarcinoma, HCT-8, cell line, relative to mouse leukemia L1210 cells. Comparative molecular field analysis (CoMFA) was applied to HCT-8 and L1210 growth inhibition assays (IC50s) of a series (44) of the pyrazoloacridine derivatives with the objective of predicting improved solid tumor selectivity. In the absence of crystallographic data, the 9-methoxy derivative (15), which is currently in clinical study, was selected as the template molecular model. Two different structural alignments were tested: an alignment of structures based on root mean square (RMS)-fitting of each structure to 15 was compared with an alternative strategy, steric and electrostatic alignment (SEAL). Somewhat better predictive cross-validation correlations (r2) were obtained with models based on RMS vis-à-vis SEAL alignment for both sets of assays. A large change in lattice spacing, e.g., 2 to 1 A, causes significant variations in the CoMFA results. A shift in the lattice of half of its spacing had a much smaller effect on the CoMFA data for a lattice of 1 A than one of 2 A. The relative contribution of steric and electrostatic fields to both models were about equal, underscoring the importance of both terms. Neither calculated log P nor HOMO and/or LUMO energies contribute to the model. Steric and electrostatic fields of the pyrazoloacridines are the sole relevant descriptors to the structure-activity (cross-validated and conventional) correlations obtained with the cytotoxic data for both the L1210 and HCT-8 cell lines. The cross-validated r2, derived from partial least-squares calculations, indicated considerable predictive capacity for growth inhibition of both the leukemia and solid-tumor data. Evidence for the predictive performance of the CoMFA-derived models is provided in the form of plots of actual vs predicted growth inhibition of L1210 and HCT-8 cells, respectively, by the pyrazoloacridines. The steric and electrostatic features of the QSAR are presented in the form of standard deviation coefficient contour maps of steric and electrostatic fields. The maps indicate that increases or decreases in steric bulk that would enhance growth inhibition of HCT-8 cells would likewise promote growth inhibition of L1210 cells. Contour maps generated to analyze the electrostatic field contributions of the pyrazoloacridines to growth inhibition provide an essentially similar set of results.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm00075a004</identifier><identifier>PMID: 8280289</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Acridines - chemistry ; Acridines - therapeutic use ; Adenocarcinoma - drug therapy ; Animals ; Antineoplastic agents ; Antineoplastic Agents - pharmacology ; Biological and medical sciences ; Colonic Neoplasms - drug therapy ; Electrochemistry ; General aspects ; Humans ; Intercalating Agents ; Leukemia L1210 - drug therapy ; Medical sciences ; Mice ; Models, Molecular ; Molecular Structure ; Pharmacology. Drug treatments ; Pyrazoles - chemistry ; Pyrazoles - therapeutic use ; Structure-Activity Relationship ; Tumor Cells, Cultured</subject><ispartof>Journal of medicinal chemistry, 1993-11, Vol.36 (23), p.3511-3516</ispartof><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a383t-6ade218e7b69b314febc06db5d4897fb1a4ea8d5878252decc8da0e2283a5afd3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm00075a004$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm00075a004$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3830709$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8280289$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Horwitz, Jerome P</creatorcontrib><creatorcontrib>Massova, Irina</creatorcontrib><creatorcontrib>Wiese, Thomas E</creatorcontrib><creatorcontrib>Wozniak, Antoinette J</creatorcontrib><creatorcontrib>Corbett, Thomas H</creatorcontrib><creatorcontrib>Sebolt-Leopold, Judith S</creatorcontrib><creatorcontrib>Capps, David B</creatorcontrib><creatorcontrib>Leopold, Wilbur R</creatorcontrib><title>Comparative molecular field analysis of in vitro growth inhibition of L1210 and HCT-8 cells by some pyrazoloacridines</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>In vitro screening of a number of 2-(aminoalkyl)-5-nitropyrazolo[3,4,5- kl]acridines has previously indicated (Sebolt, J.S.; et al. Cancer Res. 1987, 47, 4299-4304) that these compounds, in general, exhibit selective cytotoxicity against the human colon adenocarcinoma, HCT-8, cell line, relative to mouse leukemia L1210 cells. Comparative molecular field analysis (CoMFA) was applied to HCT-8 and L1210 growth inhibition assays (IC50s) of a series (44) of the pyrazoloacridine derivatives with the objective of predicting improved solid tumor selectivity. In the absence of crystallographic data, the 9-methoxy derivative (15), which is currently in clinical study, was selected as the template molecular model. Two different structural alignments were tested: an alignment of structures based on root mean square (RMS)-fitting of each structure to 15 was compared with an alternative strategy, steric and electrostatic alignment (SEAL). Somewhat better predictive cross-validation correlations (r2) were obtained with models based on RMS vis-à-vis SEAL alignment for both sets of assays. A large change in lattice spacing, e.g., 2 to 1 A, causes significant variations in the CoMFA results. A shift in the lattice of half of its spacing had a much smaller effect on the CoMFA data for a lattice of 1 A than one of 2 A. The relative contribution of steric and electrostatic fields to both models were about equal, underscoring the importance of both terms. Neither calculated log P nor HOMO and/or LUMO energies contribute to the model. Steric and electrostatic fields of the pyrazoloacridines are the sole relevant descriptors to the structure-activity (cross-validated and conventional) correlations obtained with the cytotoxic data for both the L1210 and HCT-8 cell lines. The cross-validated r2, derived from partial least-squares calculations, indicated considerable predictive capacity for growth inhibition of both the leukemia and solid-tumor data. Evidence for the predictive performance of the CoMFA-derived models is provided in the form of plots of actual vs predicted growth inhibition of L1210 and HCT-8 cells, respectively, by the pyrazoloacridines. The steric and electrostatic features of the QSAR are presented in the form of standard deviation coefficient contour maps of steric and electrostatic fields. The maps indicate that increases or decreases in steric bulk that would enhance growth inhibition of HCT-8 cells would likewise promote growth inhibition of L1210 cells. Contour maps generated to analyze the electrostatic field contributions of the pyrazoloacridines to growth inhibition provide an essentially similar set of results.</description><subject>Acridines - chemistry</subject><subject>Acridines - therapeutic use</subject><subject>Adenocarcinoma - drug therapy</subject><subject>Animals</subject><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Colonic Neoplasms - drug therapy</subject><subject>Electrochemistry</subject><subject>General aspects</subject><subject>Humans</subject><subject>Intercalating Agents</subject><subject>Leukemia L1210 - drug therapy</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Models, Molecular</subject><subject>Molecular Structure</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyrazoles - chemistry</subject><subject>Pyrazoles - therapeutic use</subject><subject>Structure-Activity Relationship</subject><subject>Tumor Cells, Cultured</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0cGLEzEUBvAgytpdPXkWchD3IKMvycwkPUrVXbFgwQq9hTdJxk2dmXSTmdX615vSUjx4CuH78Xj5QsgLBm8ZcPZu2wOArBCgfERmrOJQlArKx2QGwHnBay6eksuUtpkJxsUFuVBcAVfzGZkWod9hxNE_ONqHzpmpw0hb7zpLccBun3yioaV-oA9-jIH-iOHXeJfvd77xow_DIV0yziB7S28X60JR47ou0WZPU-gd3e0j_gldQBO99YNLz8iTFrvknp_OK_L908f14rZYfr35vHi_LFAoMRY1WseZcrKp541gZesaA7VtKluquWwbhqVDZSslFa-4dcYoi-A4VwIrbK24Iq-Pc3cx3E8ujbr36bAbDi5MScsaZFnOqwzfHKGJIaXoWr2Lvse41wz0oWT9T8lZvzyNnZre2bM9tZrzV6cck8GujTgYn84svw0kHFhxZD6N7vc5xvhT11LISq9X3_SXzYfN6mYl9Sb766NHk_Q2TDF_T_rvgn8BzGKgzA</recordid><startdate>19931112</startdate><enddate>19931112</enddate><creator>Horwitz, Jerome P</creator><creator>Massova, Irina</creator><creator>Wiese, Thomas E</creator><creator>Wozniak, Antoinette J</creator><creator>Corbett, Thomas H</creator><creator>Sebolt-Leopold, Judith S</creator><creator>Capps, David B</creator><creator>Leopold, Wilbur R</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19931112</creationdate><title>Comparative molecular field analysis of in vitro growth inhibition of L1210 and HCT-8 cells by some pyrazoloacridines</title><author>Horwitz, Jerome P ; Massova, Irina ; Wiese, Thomas E ; Wozniak, Antoinette J ; Corbett, Thomas H ; Sebolt-Leopold, Judith S ; Capps, David B ; Leopold, Wilbur R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a383t-6ade218e7b69b314febc06db5d4897fb1a4ea8d5878252decc8da0e2283a5afd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Acridines - chemistry</topic><topic>Acridines - therapeutic use</topic><topic>Adenocarcinoma - drug therapy</topic><topic>Animals</topic><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Colonic Neoplasms - drug therapy</topic><topic>Electrochemistry</topic><topic>General aspects</topic><topic>Humans</topic><topic>Intercalating Agents</topic><topic>Leukemia L1210 - drug therapy</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Models, Molecular</topic><topic>Molecular Structure</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyrazoles - chemistry</topic><topic>Pyrazoles - therapeutic use</topic><topic>Structure-Activity Relationship</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Horwitz, Jerome P</creatorcontrib><creatorcontrib>Massova, Irina</creatorcontrib><creatorcontrib>Wiese, Thomas E</creatorcontrib><creatorcontrib>Wozniak, Antoinette J</creatorcontrib><creatorcontrib>Corbett, Thomas H</creatorcontrib><creatorcontrib>Sebolt-Leopold, Judith S</creatorcontrib><creatorcontrib>Capps, David B</creatorcontrib><creatorcontrib>Leopold, Wilbur R</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Horwitz, Jerome P</au><au>Massova, Irina</au><au>Wiese, Thomas E</au><au>Wozniak, Antoinette J</au><au>Corbett, Thomas H</au><au>Sebolt-Leopold, Judith S</au><au>Capps, David B</au><au>Leopold, Wilbur R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative molecular field analysis of in vitro growth inhibition of L1210 and HCT-8 cells by some pyrazoloacridines</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1993-11-12</date><risdate>1993</risdate><volume>36</volume><issue>23</issue><spage>3511</spage><epage>3516</epage><pages>3511-3516</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>In vitro screening of a number of 2-(aminoalkyl)-5-nitropyrazolo[3,4,5- kl]acridines has previously indicated (Sebolt, J.S.; et al. Cancer Res. 1987, 47, 4299-4304) that these compounds, in general, exhibit selective cytotoxicity against the human colon adenocarcinoma, HCT-8, cell line, relative to mouse leukemia L1210 cells. Comparative molecular field analysis (CoMFA) was applied to HCT-8 and L1210 growth inhibition assays (IC50s) of a series (44) of the pyrazoloacridine derivatives with the objective of predicting improved solid tumor selectivity. In the absence of crystallographic data, the 9-methoxy derivative (15), which is currently in clinical study, was selected as the template molecular model. Two different structural alignments were tested: an alignment of structures based on root mean square (RMS)-fitting of each structure to 15 was compared with an alternative strategy, steric and electrostatic alignment (SEAL). Somewhat better predictive cross-validation correlations (r2) were obtained with models based on RMS vis-à-vis SEAL alignment for both sets of assays. A large change in lattice spacing, e.g., 2 to 1 A, causes significant variations in the CoMFA results. A shift in the lattice of half of its spacing had a much smaller effect on the CoMFA data for a lattice of 1 A than one of 2 A. The relative contribution of steric and electrostatic fields to both models were about equal, underscoring the importance of both terms. Neither calculated log P nor HOMO and/or LUMO energies contribute to the model. Steric and electrostatic fields of the pyrazoloacridines are the sole relevant descriptors to the structure-activity (cross-validated and conventional) correlations obtained with the cytotoxic data for both the L1210 and HCT-8 cell lines. The cross-validated r2, derived from partial least-squares calculations, indicated considerable predictive capacity for growth inhibition of both the leukemia and solid-tumor data. Evidence for the predictive performance of the CoMFA-derived models is provided in the form of plots of actual vs predicted growth inhibition of L1210 and HCT-8 cells, respectively, by the pyrazoloacridines. The steric and electrostatic features of the QSAR are presented in the form of standard deviation coefficient contour maps of steric and electrostatic fields. The maps indicate that increases or decreases in steric bulk that would enhance growth inhibition of HCT-8 cells would likewise promote growth inhibition of L1210 cells. Contour maps generated to analyze the electrostatic field contributions of the pyrazoloacridines to growth inhibition provide an essentially similar set of results.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>8280289</pmid><doi>10.1021/jm00075a004</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1993-11, Vol.36 (23), p.3511-3516
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_76074495
source MEDLINE; American Chemical Society (ACS) Journals
subjects Acridines - chemistry
Acridines - therapeutic use
Adenocarcinoma - drug therapy
Animals
Antineoplastic agents
Antineoplastic Agents - pharmacology
Biological and medical sciences
Colonic Neoplasms - drug therapy
Electrochemistry
General aspects
Humans
Intercalating Agents
Leukemia L1210 - drug therapy
Medical sciences
Mice
Models, Molecular
Molecular Structure
Pharmacology. Drug treatments
Pyrazoles - chemistry
Pyrazoles - therapeutic use
Structure-Activity Relationship
Tumor Cells, Cultured
title Comparative molecular field analysis of in vitro growth inhibition of L1210 and HCT-8 cells by some pyrazoloacridines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T19%3A04%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20molecular%20field%20analysis%20of%20in%20vitro%20growth%20inhibition%20of%20L1210%20and%20HCT-8%20cells%20by%20some%20pyrazoloacridines&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Horwitz,%20Jerome%20P&rft.date=1993-11-12&rft.volume=36&rft.issue=23&rft.spage=3511&rft.epage=3516&rft.pages=3511-3516&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm00075a004&rft_dat=%3Cproquest_cross%3E76074495%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76074495&rft_id=info:pmid/8280289&rfr_iscdi=true